复发性类风湿性心脏炎呈现严重的双管节功能障碍,尽管机械 mitra 门功能正常
José Victor da Nóbrega Borges1, Samira Abdel Correia Leila2
1Florida International University and Baptist Health South Florida, Miami, Florida, USA.
JACC. Case reports
|November 20, 2025
概括
复发性急性类风湿性发烧 (ARF) 可能导致门手术后成年人的心脏功能障碍. 早期诊断和治疗是管理这种罕见但严重的风湿性心脏病并发症 (RHD) 的关键.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 内部医学 内部医学
背景情况:
- 风湿性心脏病 (RHD) 是流行地区心血管疾病的重要原因.
- 在成年人中,急性类风湿性发烧 (ARF) 在门手术后的复发不常见,但至关重要.
研究的目的:
- 突出在成年人中出现复发性ARF的可能性,有RHD病史,在门置换后出现新的心脏功能障碍.
- 强调在这个患者群体中考虑复发性ARF在无法解释的心室功能障碍的差异诊断中的重要性.
主要方法:
- 一个44岁的男性患有类风湿性心肌狭窄症,经过机械心肌置换的病例介绍.
- 临床评估包括心声学和冠状动脉计算机断层扫描血管学手术后5年.
- 治疗包括抗炎疗法和针对心力衰竭的指导方针导向医学治疗.
主要成果:
- 尽管保留了假体门的功能,但患者出现了严重的双心脏缩功能障碍 (LVEF 20%) .
- 阻塞性冠状动脉疾病和肺栓塞被排除在外.
- 炎症标志物升高表明复发性类风湿性心炎,导致治疗和逐步恢复.
结论:
- 在有RHD病史的成年人中,即使在门手术后,也应考虑出现复发性ARF,因为他们经历了新的心室功能障碍.
- 手术后ARF复发可能导致心肌功能障碍,需要及时诊断和管理.
- 心声学和多模式成像对于在RHD患者中诊断和管理复发性ARF至关重要.
相关概念视频
01:22Mitral Stenosis I: Introduction
420
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420
01:23Rheumatic Heart Disease I: Introduction
415
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
415
01:26Mitral Stenosis III: Medical Management
224
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
01:20Mitral Regurgitation I: Introduction
392
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
392
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
460
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
460
01:25Mitral Regurgitation III: Medical Management
258
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
258